{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:02:50Z","timestamp":1795028570893,"version":"4.10.2"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Extended-spectrum\n                      <jats:italic>\u03b2<\/jats:italic>\n                      lactamases (ESBLs), have the ability to hydrolyze and cause resistance to various types of the\n                      <jats:italic>\u03b2<\/jats:italic>\n                      -lactam antibiotics, including the extended-spectrum (or third-generation) cephalosporins (e.g., cefotaxime, ceftriaxone, ceftazidime) and monobactams (e.g., aztreonam). ESBL-producing Gram negative bacteria is still posing significant therapeutic challenges.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess the prevalence and molecular characteristics of ESBL producing Gram negative bacilli, isolated from a cohort of pediatric patients in Gaza hospitals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 322 isolates of Gram-negative bacilli were collected from four referral pediatric hospitals in Gaza, namely: Al-Nasr, Al-Rantisi, Al-Durra and Beit Hanoun hospitals. These isolates were tested for ESBL production using the double disk synergy and CHROMagar phenotypic methods. Molecular characterization of the ESBL producing strains was performed using PCR targeting the CTX-M, TEM and SHV genes. Antibiotic profile was done using Kirby Bauer method according to Clinical and Laboratory Standard Institute.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 322 isolates tested by phenotypic methods, 166 (51.6%) were ESBL positive. The prevalence of ESBL production in Al-Nasr, Al-Rantisi, Al-Durra and Beit Hanoun hospitals was 54%, 52.5%, 45.5% and 52.8% respectively. The prevalence of ESBL production among\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      ,\n                      <jats:italic>Klebsiella pneum<\/jats:italic>\n                      oniae,\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      ,\n                      <jats:italic>Acinetobacter<\/jats:italic>\n                      spp.,\n                      <jats:italic>Proteus mirabilis<\/jats:italic>\n                      ,\n                      <jats:italic>Enterobacter<\/jats:italic>\n                      spp.,\n                      <jats:italic>Citrobacter<\/jats:italic>\n                      spp., and\n                      <jats:italic>Serratia marcescens<\/jats:italic>\n                      is 55.3%, 63.4%, 17.8%, 57.1%, 33.3%, 28.5%, 38.4%, and 4% respectively.\n                    <\/jats:p>\n                    <jats:p>ESBL production among urine, pus, blood, CSF and sputum was 53.3%, 55.2%, 47.4%, 33.3%, and 25% respectively. Out of the 322 isolates, 144 were screened for CTX-M, TEM and SHV production. Using PCR, 85 (59%) had at least one gene. The prevalence rate of CTX-M, TEM and SHV genes was 60%, 57.6%, and 38.3% respectively.<\/jats:p>\n                    <jats:p>Meropenem and amikacin were highest rates of susceptibility antibiotics against ESBLs producers (83.1% and 82.5% respectively), while the least effective antibiotics were amoxicillin (3.1%) and cephalexin (13.9%). Moreover, ESBLs producers showed high resistance rate to cefotaxime, ceftriaxone and ceftazidime (79.5%, 78.9% and 79.5% respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results show high prevalence of ESBL production among Gram negative bacilli isolated from children in different pediatric hospitals in Gaza strip. A substantial level of resistance to first and second generation cephalosporins was also observed. This ascertains the need for a rational antibiotic prescription and consumption policy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08017-1","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T06:07:12Z","timestamp":1676873232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Prevalence of extended spectrum beta lactamase and molecular detection of blaTEM, blaSHV and blaCTX-M genotypes among Gram negative bacilli isolates from pediatric patient population in Gaza strip"],"prefix":"10.1186","volume":"23","author":[{"given":"Nabil Abdullah","family":"El Aila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahed Ali","family":"Al Laham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basim Mohammed","family":"Ayesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"issue":"1","key":"8017_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13613-015-0061-0","volume":"5","author":"\u00c9 Rupp\u00e9","year":"2015","unstructured":"Rupp\u00e9 \u00c9, Woerther PL, Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care. 2015;5(1):61.","journal-title":"Ann Intensive Care"},{"issue":"3","key":"8017_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/01.JAA.0000443810.42907.ec","volume":"27","author":"SS Sutton","year":"2014","unstructured":"Sutton SS. What are extended-spectrum beta-lactamases? Jaapa. 2014;27(3):14\u20137.","journal-title":"Jaapa"},{"issue":"10","key":"8017_CR3","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1128\/jcm.35.10.2593-2597.1997","volume":"35","author":"PE Coudron","year":"1997","unstructured":"Coudron PE, Moland ES, Sanders CC. Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. J Clin Microbiol. 1997;35(10):2593\u20137.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"8017_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2047-2994-3-9","volume":"3","author":"SZ Kassakian","year":"2014","unstructured":"Kassakian SZ, Mermel LA. Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria. Antimicrob Resist Infect Control. 2014;3(1):9.","journal-title":"Antimicrob Resist Infect Control"},{"key":"8017_CR5","unstructured":"WHO. Antimicrobial resistance: global report on surveillance. 2014. http:\/\/www.who.int\/drugresistance\/documents\/surveillancereport\/en\/. Accessed 17 Feb 2018."},{"issue":"3","key":"8017_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF02724275","volume":"71","author":"JY Ang","year":"2004","unstructured":"Ang JY, Ezike E, Asmar BI. Antibacterial resistance. Indian J Pediatr. 2004;71(3):229\u201339.","journal-title":"Indian J Pediatr"},{"key":"8017_CR7","first-page":"11","volume":"17","author":"S Ghafourian","year":"2015","unstructured":"Ghafourian S, Sadeghifard N, Soheili S, Sekawi Z. Extended spectrum beta-lactamases: definition, classification and epidemiology. Curr Issues Mol Biol. 2015;17:11\u201321.","journal-title":"Curr Issues Mol Biol"},{"issue":"4","key":"8017_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"DL Paterson","year":"2005","unstructured":"Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657\u201386.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"8017_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1021\/bi501195g","volume":"54","author":"CJ Adamski","year":"2015","unstructured":"Adamski CJ, Cardenas AM, Brown NG, Horton LB, Sankaran B, Prasad BV, Gilbert HF, Palzkill T. Molecular basis for the catalytic specificity of the CTX-M extended-spectrum \u03b2-lactamases. Biochem. 2015;54(2):447\u201357.","journal-title":"Biochem"},{"issue":"1","key":"8017_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.48.1.1-14.2004","volume":"48","author":"R Bonnet","year":"2004","unstructured":"Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother. 2004;48(1):1\u201314.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"8017_CR11","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1128\/AAC.35.9.1697","volume":"35","author":"GA Jacoby","year":"1991","unstructured":"Jacoby GA, Medeiros AA. More extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1991;35(9):1697\u2013704.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"8017_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1128\/JCM.38.2.542-546.2000","volume":"38","author":"E Tzelepi","year":"2000","unstructured":"Tzelepi E, Giakkoupi P, Sofianou D, Loukova V, Kemeroglou A, Tsakris A. Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol. 2000;38(2):542\u20136.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"8017_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijantimicag.2007.09.008","volume":"31","author":"H Mehrgan","year":"2008","unstructured":"Mehrgan H, Rahbar M. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Int J Antimicrob Agents. 2008;31(2):147\u201351.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"8017_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jhin.2008.11.019","volume":"71","author":"VC Cassettari","year":"2009","unstructured":"Cassettari VC, da Silveira IR, Dropa M, Lincopan N, Mamizuka EM, Matt\u00e9 MH, Matt\u00e9 GR, Menezes PR. Risk factors for colonisation of newborn infants during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an intermediate-risk neonatal unit. J Hosp Infect. 2009;71(4):340\u20137.","journal-title":"J Hosp Infect"},{"issue":"1","key":"8017_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jhin.2010.03.008","volume":"76","author":"SS Levy","year":"2010","unstructured":"Levy SS, Mello MJ, Gusm\u00e3o-Filho FA, Correia JB. Colonisation by extended-spectrum beta-lactamase-producing Klebsiella spp. in a paediatric intensive care unit. J Hosp Infect. 2010;76(1):66\u20139.","journal-title":"J Hosp Infect"},{"issue":"6","key":"8017_CR16","first-page":"571","volume":"55","author":"J Dotis","year":"2013","unstructured":"Dotis J, Printza N, Marneri A, Gidaris D, Papachristou F. Urinary tract infections caused by extended spectrum \u03b2-lactamase (ESBL) producing bacteria in children: a matched casecontrol study. Turk J Pediatr. 2013;55(6):571\u20134.","journal-title":"Turk J Pediatr"},{"key":"8017_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2334-9-41","volume":"9","author":"KH Song","year":"2009","unstructured":"Song KH, Jeon JH, Park WB, Park SW, Kim HB, Oh MD, Lee HS, Kim NJ, Choe KW. Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study. BMC Infect Dis. 2009;9:41.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"8017_CR18","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/cid\/ciu069","volume":"58","author":"AJ Hsu","year":"2014","unstructured":"Hsu AJ, Tamma PD. Treatment of multidrug-resistant Gram-negative infections in children. Clin Infect Dis. 2014;58(10):1439\u201348.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"8017_CR19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.mib.2006.08.011","volume":"9","author":"R Cant\u00f3n","year":"2006","unstructured":"Cant\u00f3n R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol. 2006;9(5):466\u201375.","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"8017_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/420816","volume":"39","author":"DL Paterson","year":"2004","unstructured":"Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis. 2004;39(1):31\u20137.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8017_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.diagmicrobio.2010.12.008","volume":"70","author":"NY Lee","year":"2011","unstructured":"Lee NY, Huang WH, Tsui KC, Hsueh PR, Ko WC. Carbapenem therapy for bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli or Klebsiella pneumoniae. Diagn Microbiol Infect Dis. 2011;70(1):150\u20133.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"8017_CR22","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1128\/AAC.06301-11","volume":"56","author":"NY Lee","year":"2012","unstructured":"Lee NY, Lee CC, Huang WH, Tsui KC, Hsueh PR, Ko WC. Carbapenem therapy for bacteremia due to extended-spectrum-\u03b2-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility. Antimicrob Agents Chemother. 2012;56(6):2888\u201393.","journal-title":"Antimicrob Agents Chemother"},{"key":"8017_CR23","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. 26th ed., CLSI supplement M100S. Wayne: Clinical and Laboratory Standards Institute; 2018."},{"issue":"6","key":"8017_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s10156-008-0642-Z","volume":"14","author":"PR Niumsup","year":"2008","unstructured":"Niumsup PR, Tansawai U, Boonkerd N, Polwichai P, Dejsirilert S. Dissemination of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli in Thai hospitals. J Infect Chemother. 2008;14(6):404\u20138.","journal-title":"J Infect Chemother"},{"issue":"4","key":"8017_CR25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/jclinpath-2012-201234","volume":"66","author":"M Hornsey","year":"2013","unstructured":"Hornsey M, Phee L, Woodford N, Turton J, Meunier D, Thomas C, Wareham DW. Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase. J Clin Pathol. 2013;66(4):348\u201350.","journal-title":"J Clin Pathol"},{"key":"8017_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2334-9-153","volume":"9","author":"NA El Aila","year":"2009","unstructured":"El Aila NA, Tency I, Claeys G, Saerens B, De Backer E, Temmerman M, Verhelst R, Vaneechoutte M. Genotyping of Streptococcus agalactiae (group B streptococci) isolated from vaginal and rectal swabs of women at 35\u201337 weeks of pregnancy. BMC Infect Dis. 2009;9:153.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"8017_CR27","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/BF01690097","volume":"15","author":"MT N\u00fcesch-Inderbinen","year":"1996","unstructured":"N\u00fcesch-Inderbinen MT, H\u00e4chler H, Kayser FH. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis. 1996;15(5):398\u2013402.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"8017_CR28","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1128\/AAC.45.8.2269-2275.2001","volume":"45","author":"R Bonnet","year":"2001","unstructured":"Bonnet R, Dutour C, Sampaio JL, Chanal C, Sirot D, Labia R, De Champs C, Sirot J. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly. Antimicrob Agents Chemother. 2001;45(8):2269\u201375.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2\u20133","key":"8017_CR29","first-page":"203","volume":"134","author":"G Arlet","year":"1995","unstructured":"Arlet G, Brami G, D\u00e9cr\u00e8 D, Flippo A, Gaillot O, Lagrange PH, Philippon A. Molecular characterisation by PCR-restriction fragment length polymorphism of TEM beta-lactamases. FEMS Microbiol Lett. 1995;134(2\u20133):203\u20138.","journal-title":"FEMS Microbiol Lett"},{"issue":"3","key":"8017_CR30","first-page":"18","volume":"2","author":"AH Mekki","year":"2010","unstructured":"Mekki AH, Hassan AN, Elsayed DEM. Extended spectrum beta lactamases among multi drug resistant Escherichia coli and Klebsiella species causing urinary tract infections in Khartoum. Afr J Microbiol Res. 2010;2(3):18\u201321.","journal-title":"Afr J Microbiol Res"},{"issue":"2","key":"8017_CR31","first-page":"122","volume":"2","author":"ZY El Astal","year":"2008","unstructured":"El Astal ZY, Ramadan H. Occurrence of extended-spectrum beta-lactamases in isolates of Klebsiella pneumoniae and Escherichia coli. Int J Integr Biol. 2008;2(2):122.","journal-title":"Int J Integr Biol"},{"key":"8017_CR32","doi-asserted-by":"publisher","DOI":"10.3823\/775","author":"GA Tayh","year":"2016","unstructured":"Tayh GA, AL Laham NA, Elmanama AA, Slama KB. Occurrence and antimicrobial susceptibility pattern of ESBL among Gram-negative bacteria isolated from burn unit of Al Shifa hospital in Gaza,\u00a0Palestine. Int Arab J Antimicrob Agents. 2016. https:\/\/doi.org\/10.3823\/775.","journal-title":"Int Arab J Antimicrob Agents"},{"issue":"5","key":"8017_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/BMRJ\/2016\/22631","volume":"11","author":"G Adwan","year":"2016","unstructured":"Adwan G, Abu Jaber A. Frequency and molecular characterization of \u03b2-lactamases producing Escherichia coli isolated from North of Palestine. Br Microbiol Res J. 2016;11(5):1\u201313.","journal-title":"Br Microbiol Res J"},{"issue":"3","key":"8017_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/BMRJ\/2016\/27892","volume":"16","author":"M Al-Masri","year":"2016","unstructured":"Al-Masri M, Abu-Hasan N, Jouhari MM. Extended spectrum \u03b2-lactamases in clinical Isolates of Escherichia coli and Enterobacter cloacae collected from Nablus district-Palestine. Br Microbiol Res J. 2016;16(3):1\u20137.","journal-title":"Br Microbiol Res J"},{"key":"8017_CR35","first-page":"1","volume":"21","author":"N El Aila","year":"2017","unstructured":"El Aila N. Prevalence and molecular characterization of extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated from Al Shifa hospital, Gaza, Palestine. J Al-Aqsa Univ Ser Nat Sci. 2017;21:1\u201325.","journal-title":"J Al-Aqsa Univ Ser Nat Sci"},{"issue":"3","key":"8017_CR36","first-page":"133","volume":"9","author":"G Tayh","year":"2021","unstructured":"Tayh G, Al Laham N, Fhoula I, Abedelateef N, El-Laham M, Elkader Elottol A, Ben Slama K, Diseases I. Frequency and antibiotics resistance of extended-spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebsiella pneumoniae isolated from patients in Gaza Strip, Palestine. J Med Microbiol. 2021;9(3):133\u201341.","journal-title":"J Med Microbiol"},{"issue":"Suppl 1","key":"8017_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1469-0691.2007.01855.x","volume":"14","author":"PM Hawkey","year":"2008","unstructured":"Hawkey PM. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect. 2008;14(Suppl 1):159\u201365.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"8017_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1179\/joc.2009.21.4.383","volume":"21","author":"D Gur","year":"2009","unstructured":"Gur D, Hascelik G, Aydin N, Telli M, G\u00fcltekin M, Og\u00fcln\u00e7 D, Arikan OA, Uysal S, Yaman A, Kibar F, et al. Antimicrobial resistance in gram-negative hospital isolates: results of the Turkish HITIT-2 Surveillance Study of 2007. J Chemother. 2009;21(4):383\u20139.","journal-title":"J Chemother"},{"issue":"5","key":"8017_CR39","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.coph.2007.08.003","volume":"7","author":"F Perez","year":"2007","unstructured":"Perez F, Endimiani A, Hujer KM, Bonomo RA. The continuing challenge of ESBLs. Curr Opin Pharmacol. 2007;7(5):459\u201369.","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"8017_CR40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000109587","volume":"17","author":"M Al-Zarouni","year":"2008","unstructured":"Al-Zarouni M, Senok A, Rashid F, Al-Jesmi SM, Panigrahi D. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med Princ Pract. 2008;17(1):32\u20136.","journal-title":"Med Princ Pract"},{"issue":"1","key":"8017_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/mdr.2009.0096","volume":"16","author":"MM Feizabadi","year":"2010","unstructured":"Feizabadi MM, Delfani S, Raji N, Majnooni A, Aligholi M, Shahcheraghi F, Parvin M, Yadegarinia D. Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran. Microb Drug Resist. 2010;16(1):49\u201353.","journal-title":"Microb Drug Resist"},{"issue":"2","key":"8017_CR42","first-page":"171","volume":"8","author":"Z Al Muharrmi","year":"2008","unstructured":"Al Muharrmi Z, Rafay AM, Balkhair A, Al-Tamemi S, Al Mawali A, Al Sadiri H. Extended-spectrum \u03b2-lactamase (ESBL) in Omani Children: study of prevalence, risk factors and clinical outcomes at Sultan Qaboos University Hospital, Sultanate of Oman. Sultan Qaboos Univ Med J. 2008;8(2):171\u20137.","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"9","key":"8017_CR43","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1128\/AAC.00666-12","volume":"56","author":"L Chandramohan","year":"2012","unstructured":"Chandramohan L, Revell PA. Prevalence and molecular characterization of extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae in a pediatric patient population. Antimicrob Agents Chemother. 2012;56(9):4765\u201370.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"8017_CR44","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.diagmicrobio.2005.10.001","volume":"53","author":"H Goossens","year":"2005","unstructured":"Goossens H, Grabein B. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997\u20132004). Diagn Microbiol Infect Dis. 2005;53(4):257\u201364.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"73","key":"8017_CR45","first-page":"16661","volume":"10","author":"H Ejaz","year":"2011","unstructured":"Ejaz H, Zafa A, Mahmood S, Javed MM. Urinary tract infections caused by extended spectrum \u03b2-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae. Afr J Biotechnol. 2011;10(73):16661\u20136.","journal-title":"Afr J Biotechnol"},{"issue":"4","key":"8017_CR46","first-page":"197","volume":"2","author":"Z Aminzadeh","year":"2008","unstructured":"Aminzadeh Z, Sadat Kashi M, Sha\u2019bani M. Bacteriuria by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: isolates in a governmental hospital in South of Tehran, Iran. Iran J Kidney Dis. 2008;2(4):197\u2013200.","journal-title":"Iran J Kidney Dis"},{"issue":"16","key":"8017_CR47","first-page":"3921","volume":"8","author":"F Ullah","year":"2009","unstructured":"Ullah F, Malik S, Ahmed J. Antibiotic susceptibility pattern and ESBL prevalence in nosocomial Escherichia coli from urinary tract infections in Pakistan. Afr J Biotechnol. 2009;8(16):3921\u20136.","journal-title":"Afr J Biotechnol"},{"issue":"5","key":"8017_CR48","first-page":"373","volume":"20","author":"LA Degnan","year":"2015","unstructured":"Degnan LA, Milstone AM, Diener-West M, Lee CK. Extended-spectrum beta-lactamase bacteria from urine isolates in children. J Pediatr Pharmacol Ther. 2015;20(5):373\u20137.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"3","key":"8017_CR49","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0255-0857(21)02830-9","volume":"22","author":"S Babypadmini","year":"2004","unstructured":"Babypadmini S, Appalaraju B. Extended spectrum \u00df-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae\u2014prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol. 2004;22(3):172\u20134.","journal-title":"Indian J Med Microbiol"},{"key":"8017_CR50","doi-asserted-by":"publisher","first-page":"309478","DOI":"10.1155\/2015\/309478","volume":"2015","author":"MS Rezai","year":"2015","unstructured":"Rezai MS, Salehifar E, Rafiei A, Langaee T, Rafati M, Shafahi K, Eslami G. Characterization of multidrug resistant extended-spectrum beta-lactamase-producing Escherichia coli among uropathogens of pediatrics in north of Iran. Biomed Res Int. 2015;2015:309478.","journal-title":"Biomed Res Int"},{"issue":"1","key":"8017_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0255-0857(21)02706-7","volume":"23","author":"S Ananthan","year":"2005","unstructured":"Ananthan S, Subha A. Cefoxitin resistance mediated by loss of a porin in clinical strains of Klebsiella pneumoniae and Escherichia coli. Indian J Med Microbiol. 2005;23(1):20\u20133.","journal-title":"Indian J Med Microbiol"},{"issue":"1","key":"8017_CR52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/mdr.2009.0880","volume":"15","author":"F Shahcheraghi","year":"2009","unstructured":"Shahcheraghi F, Nikbin VS, Feizabadi MM. Prevalence of ESBLs genes among multidrug-resistant isolates of Pseudomonas aeruginosa isolated from patients in Tehran. Microb Drug Resist. 2009;15(1):37\u20139.","journal-title":"Microb Drug Resist"},{"issue":"2","key":"8017_CR53","first-page":"64","volume":"44","author":"AJ Al-Zahrani","year":"2005","unstructured":"Al-Zahrani AJ, Akhtar N. Susceptibility patterns of extended spectrum \u00df-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolated in a teaching hospital. Pak J Med Res. 2005;44(2):64\u20137.","journal-title":"Pak J Med Res"},{"issue":"1","key":"8017_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.18502\/sjms.v16i1.8933","volume":"16","author":"HN Altayb","year":"2021","unstructured":"Altayb HN, Siddig MA, El Amin NM, Mukhtar MM. Prevalence of blaCTX-M, blaTEM, and blaSHV genes among extended-spectrum. Sudan J Med Sci. 2021;16(1):5\u201316.","journal-title":"Sudan J Med Sci"},{"key":"8017_CR55","doi-asserted-by":"publisher","first-page":"213","DOI":"10.11604\/pamj.2020.37.213.24988","volume":"37","author":"MH Dirar","year":"2020","unstructured":"Dirar MH, Bilal NE, Ibrahim ME, Hamid ME. Prevalence of extended-spectrum \u03b2-lactamase (ESBL) and molecular detection of blaTEM, blaSHV and blaCTX-M genotypes among Enterobacteriaceae isolates from patients in Khartoum, Sudan. Pan Afr Med J. 2020;37:213.","journal-title":"Pan Afr Med J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08017-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08017-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08017-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T09:04:38Z","timestamp":1676883878000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08017-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8017"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08017-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1698826\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"assertion":[{"value":"27 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All ethical considerations and guidelines relating to the collection of the bacterial isolates of Gram negative bacilli from different pediatric hospitals in Gaza were followed. The study was approved by the department of human resources and development in the Ministry of Health\u2014Gaza.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}